• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Mad Hedge Fund Trader

Is Alibaba Investable?

Tech Letter

Chinese ecommerce company Alibaba (BABA) is essentially a proxy for the Chinese economy and that’s not a good thing lately.

The last few years have been poor.

Single digit growth for the nations’ best tech company is not going to cut it for a prototypical growth company, but it’s not all their fault.

The company has been mired in chaos amid a faltering economy.

At a national level, China is quickly turning into the next Japan with a rapidly aging workforce, a mountain of debt, and youth unemployment going through the roof.

Throw in a dollop of geopolitical strife against the biggest economy in the world and this cocktail of lethal variables has meant that its top ecommerce company is stinking up the park.

It was just 10-15 years ago when China was the place to be flourishing during a golden era of prosperity and opportunity.

Now this paper tiger, its ghost cities, and social credit system are defensive as ever with its siege mentality after the self-induced Wuhan incident. The incident literally went viral in 2020 which lead to mass lockdowns and robot dogs barking orders.

This isn’t necessarily the best backdrop for tech firms to flourish.

In a desperate way to restart growth BABA has now gone back to the well like calling for Michael Jordan to unretire for the 3rd or 4th time.

Funnily enough, they are calling on the NBA’s Brooklyn Nets owner Joe Tsai to save the company.

Tsai understands the business intimately: he was right beside Ma at Alibaba’s inception in a Hangzhou lakeside apartment in 1999.

Another former friend is also called on to save the company – Eddie Wu, current chair of the Taobao and Tmall Group which is the name of BABA’s digital platform.

The former computer science major is credited with helping develop the company’s ad platform and the PayPal-like Alipay, now part of the Ma-backed Ant Group Co.

The company never regained its stratospheric growth, particularly as new entrants such as ByteDance and Pinduoduo (PDD). sapped its core business. It began to lose market share in the cloud, its other engine of growth, to state-backed rivals.

Long-time BABA rival Baidu Inc. — once dismissed by investors as having missed the mobile revolution — introduced China’s first ChatGPT-like AI service Ernie to positive reviews, highlighting how Alibaba and its peers may be falling behind in next-generation technology.

Beyond technology, much of the market has fixated on the imminent restructuring, and its potential to unleash a half-dozen publicly traded companies, starting with more mature units like the cloud and logistics.

In Baidu’s wake, Alibaba unfurled its own large language model dubbed Tongyi Qianwen. That might be key to ensuring the company name endures 102 years, as co-founder Ma once famously and repeatedly declared was his over-arching ambition.

BABA has told us they are rolling out their new generative AI apps but the Chinese communist party has flagged as something that must go through them.

Technology intersected by authoritarianism usually ends up a failure.

Creative juices aren’t flowing and the dynamism saps the creativity juices.

I highly doubt that Chinese generative AI can hold a candle to the Silicon Valley iteration.

Nothing they have rolled out signals they are ahead of Microsoft or Google.

If readers want to get into the future of tech through stocks, avoid China and focus on the best of breed.

 

alibaba

 

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-21 16:02:442023-06-27 13:53:05Is Alibaba Investable?
Mad Hedge Fund Trader

Quote of the Day - June 21, 2023

Tech Letter

In 2017, CEO of BlackRock, Larry Fink, said: “Bitcoin just shows you how much demand for money laundering there is in the world."

In 2023, BlackRock, filed for a spot bitcoin ETF.

 

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2023/06/bitcoin-etf.png 526 460 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-21 16:00:392023-06-21 21:00:12Quote of the Day - June 21, 2023
Mad Hedge Fund Trader

June 21, 2023

Jacque's Post

 

(INTEREST RATES IN AUSTRALIA AND THE EUROZONE)

Wednesday, June 21, 2023

Hello everyone,

I hope you all had a wonderful long weekend.

Interest rates rose in the Eurozone and in Australia, but were put on pause in the U.S.

Let’s investigate.

The decision to hike another 25 basis points in Australia brings the cash rate to 4.1%, its highest level in 11 years. And there are more hikes to come to make sure inflation returns to target.

The Reserve Bank of Australia (RBA) currently forecasts headline inflation – which was running at 7% last quarter- to return to the top of its target range of 2-3% by mid-2025, a slower path than many other economies as Lowe wants to preserve strong gains in the labour market.

 

 

Mortgage owners have been hit with a 400-basis point hike in the space of a year in what has been hailed as the fastest tightening cycle on record, as inflation stays stubbornly high.

April 2023 has been the only exception, when the RBA briefly paused rates, giving mortgage holders a much-needed reprieve.

Aussies with an average loan size of $577,000 will be spending over $15,000 more per year on their mortgage compared to what they were in April last year.

Lowe has already acknowledged the risks of a more pronounced downturn in the economy, saying the path to “achieving a soft landing remains a narrow one”. The RBA is walking a tight policy rope.

It is thought that the RBA will hike again in July or August to bring rates up to 4.35%. Some of the major banks in Australia are estimating that there won’t be any rate cuts until November 2024. And the banks are also suggesting that mortgage rates could hit 7+% before they start to moderate in late 2024 and into 2025.

Many homeowners bought houses in Australia in the last few years before interest rates surged as there was a firm commitment expressed by the RBA not to raise rates until 2024. Now, many of these people are being forced to sell their homes because they can’t meet the increased costs.

Looking historically at rates from the 1970s onwards in Australia, high interest rates have not been uncommon. Rates exceeded 10% for the first time in 1974 and pretty much remained above 10% until 1995. In just 4 years, interest rates dropped from the high of 17% (January 1990) to the low of 8.75% (June 1994). After a peak of 10.5% in 1995, interest rates reached a low point of 6.5% in December 1998.

 

Average House prices in Australia increased to $896,000 (AUD) in the first quarter of 2023 from $887,500 in the fourth quarter of 2022.

 

Australian Fixed Housing Interest Rates

 

Average house prices in Australia from late 2020 to early 2023

So, what’s happening in Europe? Are they in a better position than Australia?

 

 

Last Thursday, the European Central Bank raised eurozone interest rates by a quarter-percentage point to the highest level since 2001 and they have indicated that another hike is likely as they strive to get inflation under control. The hike marks the eighth successive rate rise for the bank showing that they too are struggling to rein in price rises amid quavering economic growth.

 

The latest increase pushes the ECB’s deposit rate, which is paid on commercial bank deposits, to 3.5% - the highest since 2001. Inflation is expected to average 5.4% in 2023, before dropping to 3% in 2024, according to fresh projections from ECB staff.

The central bank’s rates cover the 19 member economies that make up the eurozone. The latest rate hike marks the sharp shift in economic forces when compared with last summer’s deposit rate of -0.5%.

Last week, revised data showed that the eurozone had slipped into recession as the rising cost of living dampened consumer spending. Economic output shrank by 0.1% in the final quarter of 2022 and the first quarter of 2023, according to official data from Eurostat. A technical recession is generally defined as two consecutive quarters of negative growth. The central bank is “very likely” to raise rates again in July as there is still ground to cover in taming inflation according to Christine Lagarde.

 

Eurozone inflation rises to 8.6%, the highest ever – The New York Times

 

Even though the US paused on raising rates last Wednesday, it seems that further rate rises are to come worldwide before peaking next year. When and by how much rates are cut will differ in each country, but the US market appears to be pricing in rate cuts as early as later this year. Let’s see if Mr. Market is correct.

Have a great week.

Cheers,

Jacquie

 


The president of the European Central Bank, Christine Lagarde, spoke in Frankfurt, Germany last Thursday.

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-21 13:00:152023-06-21 14:02:21June 21, 2023
Douglas Davenport

IS AI THE NEW BLOCKCHAIN FRENZY?

Mad Hedge AI

(TSLA), (META), (GOOGL), (MSFT), (NVDA), (BBAI), (BZFD), (AI), (RTX), (BKR), (LPSN)

Ah, the volatile world of finance, where euphoria and buzzwords can drive traders into a frenzy of speculation. In this case, the term du jour is "artificial intelligence," (AI) and it is causing quite a stir among investors.

What sparked this fervor, you might ask? None other than OpenAI’s ChatGPT.

In 2015, tech investor Sam Altman sought to do the revolutionary: create a nonprofit that would harness AI technology for the greater good of humanity. His mission was backed by powerful personalities, including Tesla's (TSLA) Elon Musk and LinkedIn co-founder Reid Hoffman, virtually ensuring success from its maiden voyage onwards.

By 2019, OpenAI launched a for-profit arm, enabling the organization to raise funds more quickly to fuel the computational power required to train its algorithms. 

When it comes to making a grand entrance, though, only a handful of apps can compete with OpenAI’s highly sought-after product: ChatGPT. 

When it was launched, the AI-powered chatbot reached a remarkable milestone: one million users in just one week. This was no easy task, given how long it took social media behemoths Facebook (META) and TikTok to amass such a large user base.

ChatGPT is essentially an electro-Mark Twain. It can not only create persuasive marketing messages and enticing ad copy, but it can also create complex computer programs.

But that isn't all. Investors are excited about ChatGPT's potential to compete with even the most established tech giants, such as Google (GOOGL).

Furthermore, this artificial intelligence chatbot technology is rapidly gaining traction in the venture capital world, and for good reason: a potentially massive $29 billion valuation. To put that in context, it's more than double the company's value from last year.

These headlines are based on talks of some serious wheeling and dealing going on behind the scenes. Two major venture capital firms are reportedly in negotiations to acquire a significant stake in OpenAI—and they're not playing around. According to reports, Thrive Capital and Founders Fund are willing to pay more than $300 million for these deals.

Needless to say, these updates reinforce the promises made when ChatGPT first swept the world.

OpenAI's remarkable success in the midst of a tumultuous tech industry is nothing short of astounding. Despite the NASDAQ's decline and the impact it has had on other companies, this innovative organization has skyrocketed to unprecedented heights with booming valuations.

With all the advancements in this booming industry, it is only natural to wonder how to get a piece of the action.

The good news is that investing in ChatGPT is not only for high-rollers. While some of the companies set to invest in the AI chatbot may require accredited investor status and deep pockets, there is still an opportunity for regular folks to get in on the action. 

You can simply invest in a publicly traded fund that has indirect exposure to ChatGPT. With this approach, you can dip your toes in the ChatGPT pool without necessarily needing a big investment account.

For instance, Microsoft (MSFT) is making a statement with their big bet on OpenAI, reportedly increasing investment to a whopping $10 billion. What began as a modest $1 billion investment in 2019 has catapulted the relationship between these two tech giants into a deeper partnership

This enormous boost will provide OpenAI with critical funding as well as cloud computing power to run increasingly complex models. In exchange, Microsoft plans to use OpenAI's technology in a variety of products, including Bing's search engine and Microsoft Design.

It is also worth noting that Nvidia Corp. (NVDA) is on everyone's lips. This semiconductor manufacturer may be best known for its graphics chips, which serve as potent fuel sources for AI software models, but it may soon achieve even greater prominence as a major player in the rapidly expanding AI development industry

As the AI hype fuels market optimism, we can expect more companies to add AI to their names and jump on the secondary stock offering bandwagon. After all, we're still in the early stages of the AI boom, and we can expect even more businesses to follow suit in the coming months.

Consider BigBear.ai Holdings Inc. (BBAI), which has seen its share price nearly fivefold increase as a result of its use of AI to assist clients in data analysis.

Or BuzzFeed Inc. (BZFD), a media company that has struggled with digital advertising, saw its stock price increase by more than 300% in just two days after announcing its plan to integrate AI-based content into its "core business."

C3.ai Inc. (AI) is one of the top-performing software makers, with a 77% rally last month, driven by customers like Raytheon Technologies Corp. (RTX) and Baker Hughes Co (BKR). 

LivePerson Inc. (LPSN) is making waves with plans to integrate generative capabilities from OpenAI, causing its shares to surge by as much as 19%. 

Meanwhile, Baidu Inc. is the latest company to jump on the chatbot bandwagon, with plans to launch its own version of ChatGPT. Unfortunately, the news did not increase the company's stock price.

Once again, the stock market is rife with euphoria over the newest technology craze. For those who've been around the block a few times, the situation is starting to feel a little too familiar. Remember the blockchain frenzy of 2017? Yes, this feels like déjà vu.

Back then, everyone was vying for a piece of the action, from companies to traders, only to see their stock gains evaporate faster than a snowman in July. Now, it's happening all over again with AI.

Make no mistake: AI is a paradigm-shifting technology with unfathomable growth and innovation potential. Nonetheless, as with any burgeoning fashion, buyers should proceed with caution. After all, not all AI companies are created equal, and not all investments are profitable.

That is not to say that investors should avoid AI entirely; far from it. However, they should be aware of the risks involved and conduct thorough research before jumping in with both feet. Because, while AI may be the future, the path to riches is paved with caution rather than blind enthusiasm.

Midjourney prompt: “a blockchain bull”

https://www.madhedgefundtrader.com/wp-content/uploads/2023/06/ss-062123-mhai-c8.jpg 661 930 Douglas Davenport https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Douglas Davenport2023-06-21 10:30:032023-06-21 10:34:46IS AI THE NEW BLOCKCHAIN FRENZY?
Mad Hedge Fund Trader

June 21, 2023

Diary, Newsletter, Summary

Global Market Comments
June 21, 2023
Fiat Lux

Featured Trades:

(WEDNESDAY, JULY 19, 2023 LONDON GLOBAL STRATEGY LUNCHEON)
(THE BUY AND FORGET PORTFOLIO),
(SPY), (IXUS), (EEM), (VNQ), (TLT), (TIP)

 

CLICK HERE to download today's position sheet.

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-21 09:06:212023-06-21 12:34:49June 21, 2023
Mad Hedge Fund Trader

SOLD-OUT - Wednesday, July 19, 2023 London Global Strategy Luncheon

Diary, Luncheon, Newsletter

 

Come join me for lunch for the Mad Hedge Fund Trader’s Global Strategy Update, which I will be conducting in London at 12:30 PM on Wednesday, July 19, 2023. A three-course lunch is included. I’ll be giving you my up-to-date view on stocks, bonds, currencies commodities, precious metals, and real estate.

And to keep you in suspense, I’ll be throwing a few surprises out there too. Enough charts, tables, graphs, and statistics will be thrown at you to keep your ears ringing for a week. Tickets are available for $298.

I’ll be arriving early and leaving late in case anyone wants to have a one-on-one discussion, or just sit around and chew the fat about the financial markets.

The lunch will be held at a private club on St. James Street, the details of which will be emailed to you with your purchase confirmation.

I look forward to meeting you, and thank you for supporting my research.

To purchase tickets for this luncheon, please click here or click on the Buy Now! above.

 

https://www.madhedgefundtrader.com/wp-content/uploads/2016/06/London.jpg 467 619 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-21 09:04:022023-06-29 09:59:48SOLD-OUT - Wednesday, July 19, 2023 London Global Strategy Luncheon
Mad Hedge Fund Trader

The Buy and Forget Portfolio

Diary, Newsletter

All traders and portfolio managers with experience approaching a half-century, like myself and a handful of close friends, agree on one thing.

Someday, you will be wrong.

I don’t mean just a little bit wrong, I mean disastrously wrong. A real humdinger, even a life-threatening experience. Even wrong up the wazoo.

In fact, most old salts, even the best performing ones, suffer at least a couple of 50% losses of their total assets, and at least one 75% hit, at least once in their lives.

We’ve all been there.

The 1973 oil crisis. The 1987 stock market crash, when the Dow Average gave up a withering 22% in a single day (I tried to place an order to buy stock at the close and the clerk burst into tears and dissolved into a puddle on the floor).

The Dotcom crash. And of course, the granddaddy of them all, the Great Crash of 2008, which you all remember with the greatest discomfort.

Even my mentor, Warren Buffet, has admitted to taking three 50% hits in his lifetime and lived to tell about it.

The trick is to keep these misfortunes from wiping you out so completely that you can never make a comeback.

Better yet, don’t get into trouble in the first place. And I’ll tell you exactly how to do that right now.

One of the great pleasures of running the Mad Hedge Fund Trader is that I get to speak to thousands of interesting people every year. Believe me, there are all kinds.

I have found kids straight out of school who take to trading like a fish to water. Their instincts are incredible. They figure out the harsh realities of the market decades before I ever did.

When they ask me questions, I think, “Damn! Why didn’t I think of that?”

I have seen several of these gifted, natural born traders use the Mad Hedge Fund Trader turn pennies into millions over unbelievably short times.

You see, they have the trader gene.

Sadly, I also run into the opposite extreme. With some people you could have George Soros sitting on their left, Paul Tudor Jones on their right, both guiding their hands on the mouse to execute trades, and they are still going to still lose money.

These are not stupid people.

I have met many with Harvard MBAs, advanced degrees from MIT, and even Phi Beta Kappa’s, and it doesn’t do them a whit of good on the trading front. They just don’t have trading in them.

In other words, they lack the trading gene.

When I stumble across these people, I tell them to quit trading, end the self-abuse, and preserve whatever wealth they have left. I then order them to buy what I call my “Buy and Forget Portfolio.”

This is a collection of only six investments, which I have assembled over the decades that will be profitable in almost all circumstances. In good years it will grow generously. In bad years it will be down marginally. Over the long term, it will do extremely well.

Here it is:

The Mad Hedge Buy and Forget Portfolio

20% domestic US stocks (SPY)
20% international stocks (IXUS)
10% emerging stock markets (EEM)
20% Real Estate Investment Trusts (VNQ)
15% long term US Treasury Bonds (TLT)
15% Treasury Inflation Protected Securities (TIP)

Notice that half the money is in equities and the remainder in fixed income securities.

If you initiated this portfolio in 1997, the year that TIPS first became available to the public, you would have earned an average annualized compounded return of 7.86% through the end of 2014, assuming reinvestment of dividends and interest.

During the bear market of 2000-2002, when the S&P 500 dropped 50%, this portfolio never suffered a loss of more than -4.7%. During the Great Crash of 2008, it fell -31%, versus -37% for the (SPY), and then very quickly bounced back.

Most long-only investors would have killed for returns like these.

So the bottom line is this. Expect a 4% drawdown every decade, a 31% hickey twice a century, and one of those twice-a-century events is only eight years behind us. That is not a bad proposition.

The heavy stock weighting can be easily explained by the fact that historically, stocks have outperformed bonds by a large margin.

For long periods of time, such as much of the 19th century, the Great Depression, and now, chronic structural deflation meant that bonds paid very little in interest.

Stocks also have the advantage in that during periods of inflation they can pass rising costs on to consumers via price hikes.

Guess what? We are just going into an inflationary period.

For the past 200 years, stocks have therefore delivered a compounded average annualized return of 8.3%.

Just to give you an example of how valuable the stock advantage can be, $1 invested in 1802 would be worth $8.8 million today.

This is why Oracle of Omaha Warren Buffet constantly sings the praises of compounding and dividend reinvestment and is why he rarely sells anything. In fact, his authorized biography is entitled Snowball (a great read, by the way).

The beauty of the Buy and Forget Portfolio is that the six elements counterbalance each other in all market circumstances. When stocks go up, bonds usually go down, and vice versa.

They both go the wrong way only for very short periods, such as in 2008 and always snap back.

And remember inflation, that long-forgotten thing where prices actually go up? It will make a return someday. And there is no better time to buy TIPS than during the deflationary surge that we are enduring now. TIPS prices are cheap.

Such is the beauty of diversification.

The great thing about the Buy and Forget Portfolio is that you can literally buy and forget about it. You won’t lose sleep at night, you could care less about what they say on CNBC, and don’t have to hide those embarrassing brokerage statements from your spouse.

The only thing you have to do is to rebalance it once a year to restore each component to its original weighting. More often than that and you run up big commission and tax bills.

Remember, you are trying to buy your own yacht, not your broker’s.

This will free you up to focus on the more important things in life.

Will Daenerys Targaryen gain her rightful place on the throne of the Seven Kingdoms in The Game of Thrones? Will Don Draper get his well-deserved comeuppance in the final season of Mad Men? Can the widow, Lady Mary, ever find true love again in the next season of Downton Abbey?

Of course, knowing all of this, some bad traders will continue to trade. For some, it is like an addition. They just have to win, whatever the cost. For others, it's like buying lottery tickets. Some just love the adrenaline and the thrill of the chase, even if it costs them money.

Whatever the reason, they continue trading until they run out of money. Then they will try to borrow your money to trade.

Could this be you?

All I can do is wish them the best.

Leave the trading to the masochists, like me.

 

 

 

 

 

Leave the Trading to the Masochists

https://www.madhedgefundtrader.com/wp-content/uploads/2017/12/john-snow-e1514508880916.jpg 333 250 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-21 09:02:342023-06-21 12:36:10The Buy and Forget Portfolio
Mad Hedge Fund Trader

SOLD OUT - Saturday, August 5, 2023 Rome, Italy Global Strategy Luncheon

Lunch

 

Come join me for lunch at the Mad Hedge Fund Trader’s Global Strategy Update, which I will be conducting in Rome, Italy at 12:30 PM on Saturday, August 5, 2023. An excellent meal will be followed by a wide-ranging discussion and an extended question-and-answer period.

I’ll be giving you my up-to-date view on stocks, bonds, currencies, commodities, precious metals, and real estate. And to keep you in suspense, I’ll be throwing a few surprises out there too. Tickets are available for $286.

I’ll be arriving on time and leaving late in case anyone wants to have a one-on-one discussion, or just sit around and chew the fat about the financial markets.

The lunch will be held at an exclusive private restaurant in the heart of historic Rome, right on the beautiful Piazza Navona. The precise location will be emailed with your purchase confirmation.

I look forward to meeting you and thank you for supporting my research. 

To purchase tickets for the luncheons, please click the BUY NOW! button above or click here.

 

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2023/06/rome.jpg 324 452 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-21 09:00:052023-07-31 14:52:39SOLD OUT - Saturday, August 5, 2023 Rome, Italy Global Strategy Luncheon
Mad Hedge Fund Trader

June 20, 2023

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
June 20, 2023
Fiat Lux

Featured Trade:

(THE RISE OF THE TRILLION-DOLLAR PHARMA)
(LLY), (NVO), (AAPL), (MSFT)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-20 18:02:382023-06-20 19:19:50June 20, 2023
Mad Hedge Fund Trader

The Rise of the Trillion Dollar Pharma

Biotech Letter

It's hardly a surprise when we think of titans like Apple (AAPL) and Microsoft (MSFT) topping the trillion-dollar club. After all, these tech leviathans have their tendrils in the lives of billions worldwide.

But guess what? This playground isn't just for tech heavyweights.

There's another contender in the ring, flexing its muscles from the biotechnology and healthcare sector: Eli Lilly (LLY).

Even as I write, I can almost hear the gears of potential turning. Eli Lilly could soon be donning the badge of the biopharma representative in the trillion-dollar league. What's more, this could happen sooner than you might think—say, before we're toasting to 2030.

Today, Eli Lilly stands proud with a market cap hovering over $410 billion, rubbing shoulders with the crème de la crème of the pharmaceutical world.

To reach the coveted trillion by 2030, it needs to rev up its growth engine by almost 166% in the next six or so years.

Given that its market cap ballooned by 178% since May 2020, we're not betting against the odds here.

Let's dissect this potential behemoth and scrutinize its growth prospects, valuation, and their likely dance over time.

With a trailing 12-month net income of $6.2 billion and a price-to-earnings ratio lingering around 69, Eli Lilly isn't exactly shy.

This valuation is higher than the industry standard but not bloated like some tech stocks.

Credit its remarkable net income growth of around 14% per annum over the last decade to persistent R&D investment, the frequent launch of new sought-after medicines, and strategic label expansions for its already-approved drugs.

Now, the market is giddy with anticipation, pricing in growth that surpasses its own impressive average. This is likely due to Eli Lilly's ambitious ventures into thriving markets with treatments for conditions like diabetes, obesity, and chronic kidney disease.

If Eli Lilly maintains its current PE ratio and boosts its earnings by a mere 13.5% each year between now and 2030, it will rake in a net income of about $15.1 billion, nudging its market cap just above $1 trillion.

A lofty goal? Perhaps, but Eli Lilly isn't one to back away from a challenge.

The question hanging in the air like an eager balloon is whether the company can maintain this steady pace.

Analysts are optimistic, predicting an EPS of $8.76 in 2023 and around $16 in 2025. This promising growth is tied to the launch of new medicines from its four programs awaiting approval decisions and a Phase 3 roster filled with 21 promising programs.

Meanwhile, Eli Lilly is acing its game in another affluent market: obesity treatments.

The company has long been a trailblazer in diabetes and obesity drugs, and its recent approval of Mounjaro, a revolutionary treatment for Type 2 diabetes, adds another feather to its cap.

Mounjaro has made waves, garnering $568.5 million in sales in the first quarter, and is predicted to hit peak annual revenue of $25 billion.

Obesity, a global health concern responsible for at least 2.8 million deaths yearly, opens up another massive market for Eli Lilly.

Branded anti-obesity drugs could hit $44 billion in risk-adjusted sales by 2030, up from a modest $2.5 billion in 2022.

As it stands, Eli Lilly's primary contender in this arena is Novo Nordisk (NVO).

So, can Eli Lilly flex its muscles and reach a market cap of $1 trillion by 2030? Signs point to a resounding yes.

With a steady stream of treatments on the horizon and a projected growth trajectory through the end of the decade, it seems to be business as usual for Eli Lilly.

However, like a precarious game of Jenga, the entire venture hinges on its valuation. As long as investors see sunny days ahead, all's well. But maintaining a P/E ratio of around 70 isn't a walk in the park. A dip in performance or a market crash could bring the whole structure down.

That being said, don't let these concerns hold you back from joining Eli Lilly's growth ride. Come 2030, you'll probably be smiling at your investment, whether or not Eli Lilly cracks that 13-digit milestone.

 

eli lilly growth

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 Mad Hedge Fund Trader https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Mad Hedge Fund Trader2023-06-20 18:00:342023-06-27 14:22:46The Rise of the Trillion Dollar Pharma
Page 6 of 14«‹45678›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
  • Privacy Policy
  • Disclaimer
  • FAQ
Scroll to top